Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia
Clinical trial NCT00782067 · COMPLETED
Trial details
- NCT number
- NCT00782067
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-13
- Primary completion
- 2014-12-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.